NANOSPAIN

Related News

ICN2 Plasmonic Biosensor for COVID and other conditions [02-03-2022]
An innovative nano-biosensor assay for fast, quantitative and accurate COVID-19 serology, has been developed by a team of researchers led by Prof. Laura M. Lechuga, head of the NanoBiosensors and Bioanalytical Applications Group at the Catalan Institute of Nanoscience and Nanotechnology (ICN2, Barcelona, Spain). The sensor combines the high reliability of specialised laboratory analysis with the short turnaround times and simple operability of rapid self-tests.

Macrophages Polarized to Kill Cancer Cells with Nanotechnology [11-07-2022]
Nanobiotechnology, Nanomedicine

Nanoparticle "backpacks" restore damaged stem cells [08-07-2022]
Nanobiotechnology

Nanoparticle vaccine protects against a spectrum of COVID-19-causing variants and related viruses [05-07-2022]
Nanobiotechnology, Nanomedicine

Nano-sensor detects pesticides on fruit in minutes [07-06-2022]
Nanosensors & Nanodevices

Protein nanoparticle vaccine shows potential for broader, safe SARS-CoV-2 vaccines [26-05-2022]
Nanobiotechnology, Nanomedicine